CDTX - Cidara Therapeutics, Inc.

QQQ $ 427.34 $ 2.10 (0.49 %)

DIA $ 382.46 $ 0.98 (0.26 %)

SPY $ 505.53 $ 1.13 (0.22 %)

TLT $ 88.97 $ 0.75 (0.85 %)

GLD $ 213.53 $ 0.92 (0.43 %)

Previous Close

$ 11.81

Open

$ 11.62

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 11.62 - $ 12.47

52 Week Range

$ 10.00 - $ 29.60

Volume

107,666

Average Volume

Market Cap

51.63M

Beta (5Y Monthly)

$ 1.24

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	04-22-2024	12-31-2023	10-K
2	11-02-2023	09-30-2023	10-Q
3	08-03-2023	06-30-2023	10-Q
4	05-11-2023	03-31-2023	10-Q
5	03-23-2023	12-31-2022	10-K
6	11-03-2022	09-30-2022	10-Q
7	08-09-2022	06-30-2022	10-Q
8	05-11-2022	03-31-2022	10-Q
9	03-07-2022	12-31-2021	10-K
10	11-10-2021	09-30-2021	10-Q
11	08-12-2021	06-30-2021	10-Q
12	05-13-2021	03-31-2021	10-Q
13	02-25-2021	12-31-2020	10-K
14	11-05-2020	09-30-2020	10-Q
15	08-13-2020	06-30-2020	10-Q
16	05-13-2020	03-31-2020	10-Q
17	03-04-2020	12-31-2019	10-K
18	11-08-2019	09-30-2019	10-Q
19	08-08-2019	06-30-2019	10-Q
20	05-09-2019	03-31-2019	10-Q
21	02-28-2019	12-31-2018	10-K
22	11-08-2018	09-30-2018	10-Q
23	08-09-2018	06-30-2018	10-Q
24	05-10-2018	03-31-2018	10-Q
25	02-27-2018	12-31-2017	10-K
26	11-08-2017	09-30-2017	10-Q
27	08-09-2017	06-30-2017	10-Q
28	05-10-2017	03-31-2017	10-Q
29	03-15-2017	12-31-2016	10-K
30	11-10-2016	09-30-2016	10-Q
31	08-11-2016	06-30-2016	10-Q
32	05-12-2016	03-31-2016	10-Q
33	03-18-2016	12-31-2015	10-K
34	11-16-2015	09-30-2015	10-Q
35	08-11-2015	06-30-2015	10-Q
36	05-21-2015	03-31-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

WBB Securities Maintains Strong Buy on Cid...
04/25/2024 19:30:34

WBB Securities analyst Stephen Brozak maintains Cidara Therapeutics (NASDAQ:CDTX) with a Strong Buy, adjusts target to $40 (rev...

Needham Maintains Buy on Cidara Therapeuti...
04/25/2024 18:23:28

Needham analyst Joseph Stringer maintains Cidara Therapeutics (NASDAQ:CDTX) with a Buy, adjusts target to $25 from $3.

Why Caterpillar Shares Are Trading Lower B...
04/25/2024 17:57:17

Cantor Fitzgerald Reiterates Overweight on...
04/25/2024 14:32:57

Cantor Fitzgerald analyst Louise Chen reiterates Cidara Therapeutics (NASDAQ:CDTX) with a Overweight.

Market-Moving News for April 25th
04/25/2024 12:31:16

ULBI: 26% | Ultralife shares are trading higher after the company reported better-than-expected Q1 financial results.CDTX: 41% ...

why-teradyne-shares-are-trading-higher-by-over-8-here-are-20-stocks-moving-premarket

Why Teradyne Shares Are Trading Higher By ...
04/25/2024 10:12:22

Cidara Therapeutics Reacquires Global Deve...
04/24/2024 20:47:52

- $240 million private placement financing led by RA Capital Management with significant participation by Bain Capital Life Sci...

Cidara Therapeutics Announces Divestiture ...
04/24/2024 20:46:09

Transaction provides company with an estimated approximately $128 million in cost savings, including approximately $67 million ...

Trading Halt: Halt status updated at 8:55:...
04/24/2024 12:55:05

Trading Halt: Halted at 7:50:00 p.m. ET - ...
04/23/2024 23:50:04

why-nucor-shares-are-trading-lower-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Nucor Shares Are Trading Lower? Here A...
04/23/2024 17:53:09

Cantor Fitzgerald Reiterates Overweight on...
04/23/2024 12:54:06

Cantor Fitzgerald analyst Louise Chen reiterates Cidara Therapeutics (NASDAQ:CDTX) with a Overweight.

Why Hibbett Shares Are Trading Higher By 1...
04/23/2024 12:00:50

Cidara Therapeutics Q4 EPS $(0.04) Beats $...
04/22/2024 21:12:58

Cidara Therapeutics (NASDAQ:CDTX) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $...

Cidara Therapeutics Announces Receipt Of N...
04/22/2024 21:08:20

Cidara Therapeutics, Inc. (NASDAQ:CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to de...

why-cidara-therapeutics-cdtx-stock-is-falling

Why Cidara Therapeutics (CDTX) Stock Is Fa...
04/22/2024 19:52:31

Cidara Therapeutics shares are trading lower by 24.4% Monday afternoon. The company announced a 1-for-20 reverse stock split.

Cidara Therapeutics Announces 1-For-20 Rev...
04/22/2024 12:50:37

Cidara Therapeutics, Inc. (NASDAQ:CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to de...

HC Wainwright & Co. Maintains Buy on Cidar...
04/08/2024 18:20:33

HC Wainwright & Co. analyst Ed Arce maintains Cidara Therapeutics (NASDAQ:CDTX) with a Buy and maintains $6 price target.

Cidara Therapeutics Presents Promising New...
04/05/2024 19:15:47

- Multispecific CD73/PD-1 DFC demonstrates improved tumor reduction compared to PD-1 monotherapy in nonclinical study- CCR5-tar...

Cidara Therapeutics To Present Preclincal ...
03/06/2024 13:09:47